2nd study testing a COVID-19 antibody drug has a setback - The Associated Press
- 2nd study testing a COVID-19 antibody drug has a setback The Associated Press
- Regeneron halts trial of COVID-19 antibody drug in sickest hospitalized patients | TheHill The Hill
- New COVID-19 Study Reveals Major Vitamin D Deficiency — But There's a Solution mindbodygreen.com
- Trial of Regeneron’s Covid-19 Antibody Drug Is Halted in Sickest Hospital Patients The Wall Street Journal
- Regeneron says IDMC recommends halt of some REGN-COV2 trial enrollment for safety risks MarketWatch
- View Full Coverage on Google News